RT Journal Article
SR Electronic
T1 Analysis of the COVID-19 epidemic in french overseas department Mayotte based on a modified deterministic and stochastic SEIR model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.15.20062752
DO 10.1101/2020.04.15.20062752
A1 Manou-Abi, Solym Mawaki
A1 Balicchi, Julien
YR 2020
UL http://medrxiv.org/content/early/2020/04/17/2020.04.15.20062752.abstract
AB In order to anticipate a future trends in the development of the novel coronavirus COVID-19 epidemic starting early at march 13, in the french overseas department Mayotte, we study in this paper a deterministic and stochastic epidemic model through several possible states: susceptible, exposed, infected including symptomatics and asymptomatics cases, simple or mild removed, severe removed (including hospitalized) and death cases. We first fit the constant transmission rate parameter to the epidemic data in Mayotte during an early exponential growth phase using an algorithm with a package R0 and based on the ML method. Thus, after the intervention and control measures imposed by the gouvernement, we introduce a simple temporally varying and exponentially decreasing transmission rate with a control parameter. This allows us to understand wheter these interventions are having the desired impact of controlling the epidemic by pointing out some percentages to maintain control which is critical in Mayotte given the fragility of its health infrastructure and the significant fraction of the population without access to water.Competing Interest StatementThe authors declare that there is no conflict of interest regarding the pre-publication of this paper.Funding StatementThe authors are gratefull to the staff of ARS-Mayotte for usefull informations. This paper will be performed in the following days.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://www.mayotte.ars.sante.fr/coronavirus-covid-19-point-de-situation-et-conduite-tenir https://www.mayotte.ars.sante.fr/coronavirus-covid-19-point-de-situation-et-conduite-tenir